en

PRODUCT DETAIL

NULOJIX 250 mg prášok na infúzny koncentrát

Code 09506
MA number EU/1/11/694/001
Product Form: plc ifc 1x250 mg (liek.inj.skl.+striek.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA28 Belatacept
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 17.06.2011
SmPC + PL: European Medicines Agency's database
Dokument: DHPC Nulojixe 18 3 2013.PDF  
Safety feature Yes
Data update: 13.05.2021
eu-flag.png sk-flag.png